The tribunal was hearing a matter where it had taken suo motu (on...
Category:
Indian News
Latest
Seven dead more than 40 injured in massive blast at chemical factory in Thane district
Five men and two women were killed in the incident but their bodies...
India to get rating support if it uses RBI dividend to reduce deficit: S&P
"The additional dividends from the RBI are around 0.35 per cent of...
Reliance partners with Google, FB for digital payment network bid: Report
Last year, India’s central bank invited companies to forge new umbrella entities (NUEs) to create a payments network that would rival the system operated by the National Payments Council of India (NPCI), as it seeks to reduce concentration risks in the space.
COVID-19 crisis far from over; 3rd wave to be more dangerous: CSIR officia
Cautioning the people and the scientific community against allowing “complacency to set in,” he warned that a third wave would precipitate a far more dangerous situation than the challenge the country had faced so far.
Mobile app improves price data collection, says govt
The department is also utilising the services of Agriwatch for providing market intelligence, predictive analysis of prices and to develop price forecasting model. The department said it had proposed to DEA (department of economic affairs) for technical assistance fund under CARES Progamme of Asian Development Bank (ADB) for improving price monitoring and analysis.
Pvt health insurers offering 80-100 pc discounts on renewal premia for healthy customers
Aditya Birla Health will give a customer up to 100 per cent health returns if the insured earned enough health returns by looking after his/her health by being physically active on a regular basis.
Rare Disease Day: Health advocacy groups press for govt policy, say India’s numbers unknown
Rare diseases, including genetic disorders such as Hunter syndrome, Gaucher disease and Fabry’s disease, are expensive to treat, difficult to identify and extract a huge toll, mostly on the young, the experts said ahead of Rare Disease Day on Sunday.
Rare diseases are also not covered by insurance policies. It is imperative the government steps in to help these patients so they can lead a near normal life, Health groups in India said.
They have also urged the government to make newborn screening mandatory to be able to identify genetical problems at an early stage. The monthly treatment cost of such diseases can be anywhere between Rs 10 lakh and Rs 50 lakh, they said.
Fintech players get $2.7 bn from VCs in 2020: Report
As against this, global fintech investments stood at a whopping $105 billion across 2,861 deals in the year, the third-highest annual total ever, as per the data collated by KPMG India.
Govt sets 50 lakh users threshold to define ‘significant social media intermediary’ under IT rules
The move aims to make social media platforms like Facebook, WhatsApp, Twitter and Instagram – which have seen a phenomenal surge in usage over the past few years in India – more accountable and responsible for the content hosted on their platform.
Govt fixes Covid vaccine price at Rs 250 a shot for pvt hospitals
The Union Government has fixed the price of vaccines at Rs 250 for a dose which would be available at private hospitals for people above 60 years of age and those above 45 years of age with comorbidities, and will be vaccinated starting March 1, sources said.
The government has decided that the people will be vaccinated free of cost at the government hospitals.
The cost break-up is Rs 150 for a dose plus Rs 100 as a service charge which the private facilities can charge from the beneficiaries.
Govt plans two-day halt in vaccinations for software upgrade to widen campaign
“The countrywide vaccination exercise is being exponentially expanded,” the ministry said in a statement, adding that a new version of its Co-Win digital platform was being rolled out at the weekend.
Co-Win, wrapped into a government mobile telephone app, is being widely used to fix vaccination appointments, allow health authorities to monitor supplies and download proof of immunisation.
Indians allowed to choose vaccination sites as government seeks faster roll-out
But the inoculation campaign has progressed slower than expected due to a reluctance of health and front-line workers to take the home-grown COVAXIN shot that was approved without late-stage efficacy data. Only 11% of vaccinated people have opted for the product developed by Bharat Biotech and the state-run Indian Council of Medical Research.
With the world’s highest tally of infections after the United States, India wants to vaccinate 300 million of its 1.35 billion people by August. The decision to give people a choice of vaccines could now speed up the roll-out, officials believe.